PeproTech重組人Fetuin A/AHSG 100ug-細(xì)胞/細(xì)菌培養(yǎng)-試劑-生物在線

女人与狗锁死了视频大全|霍金死亡过程恐怖视频|无节社团简谱季免费观看|六间房直播大厅|中文字幕欧美另类精品|久久人人玩人妻潮喷内射人人|亚洲国产一区二区三区在线观看

美國(guó)PeproTech(派普泰克)公司中國(guó)代表處
PeproTech重組人Fetuin A/AHSG 100ug

PeproTech重組人Fetuin A/AHSG 100ug

商家詢價(jià)

產(chǎn)品名稱： PeproTech重組人Fetuin A/AHSG 100ug

英文名稱： Recombinant Human Fetuin A/AHSG

產(chǎn)品編號(hào)： 140-13

產(chǎn)品價(jià)格： 0

產(chǎn)品產(chǎn)地： 美國(guó)

品牌商標(biāo)： PeproTech

更新時(shí)間： null

使用范圍： null

美國(guó)PeproTech(派普泰克)公司中國(guó)代表處
  • 聯(lián)系人 :
  • 地址 :  江蘇省蘇州市工業(yè)園區(qū)星湖街218號(hào)A1北座4樓L03
  • 郵編 : 215123
  • 所在區(qū)域 : 江蘇
  • 電話 : 點(diǎn)擊查看
  • 傳真 : 點(diǎn)擊查看
  • 郵箱 : peprotech.infochina@thermofisher.com

 
Recombinant Human Fetuin A/AHSG
Catalog Number:
140-13
Synonyms:
Alpha-2-HS-glycoprotein, Alpha-2-Z-globulin, Ba-alpha-2-glycoprotien
Description:
Fetuin A/AHSG is a human plasma glycoprotein belonging to the Cystatin family of proteases inhibitors. It is highly expressed in embryonic cells and adult hepatocytes, and is expressed to a lesser extent in monocytes/macrophages. Fetuin A/AHSG is a major serum protein component that exerts various calcium dependent physiological activities, and can mediate growth signaling in certain tumor cells. It also can act as a natural antagonist against specific TGF-β and BMP signaling proteins, Recombinant human Fetuin-A is a heterodimeric protein containing a 282 amino acid A chain and a 27 amino acid B chain. Due to glycosylation, recombinant Fetuin-A migrates at an apparent molecular weight of 45 – 55 kDa by SDS-PAGE run under non-reducing conditions.
AA Sequence:
APHGPGLIYR QPNCDDPETE EAALVAIDYI NQNLPWGYKH TLNQIDEVKV WPQQPSGELF EIEIDTLETT CHVLDPTPVA RCSVRQLKEH AVEGDCDFQL LKLDGKFSVV YAKCDSSPDS AEDVRKVCQD CPLLAPLNDT RVVHAAKAAL AAFNAQNNGS NFQLEEISRA QLVPLPPSTY VEFTVSGTDC VAKEATEAAK CNLLAEKQYG FCKATLSEKL GGAEVAVTCT VFQTQPVTSQ PQPEGANEAV PTPVVDPDAP PSPPLGAPGL PPAGSPPDSH VLTVVQPSVG AAAGPVVPPC PGRIRHFKV
Source:
HEK293 cells
Purity:
Greater than 98% by SDS-PAGE gel and HPLC analyses.
Biological Activity:
Determined by its ability to inhibit Cathespin V cleavage of a fluorogenic peptide substrate Z-LR-AMC (RLUs). The expected IC50 is ≤ 100nM.
?
?
?
?
Research Interests:
?
?
Country of Origin:
USA
Research Use Only. Not for use in diagnostic or therapeutic procedures.